Skip to content
healthcare.dev

Exelon

NDC 0078-0501, rivastigmine, patch, extended release, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0501
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022083
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE4.6 mg/24h

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
0078-0501-150007805011530 PATCH in 1 CARTON (0078-0501-15) / 24 h in 1 PATCH (0078-0501-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0
  • NADAC price for package 00078050115

    GET /v1/drugs/nadac/00078050115

Use it

Look up 0078-0501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.